SC 13G

Company

Celldex Therapeutics, Inc.

Filed

December 9, 2016

Accession Number

0001193125-16-789419

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →